Global Glaucoma Surgery Devices Market to 2019 by Type (Glaucoma Drainage, Implants & Stents, Glaucoma Laser Devices, Glaucoma Systems), by End User (Private Eye Clinics, Hospitals), by Geography
DUBLIN, Oct. 14, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/hkf3n4/global_glaucoma) has announced the addition of the "Global Glaucoma Surgery Devices Market by Type (Glaucoma Drainage, Implants & Stents, Glaucoma Laser Devices, Glaucoma Systems), by End User (Private Eye Clinics, Hospitals), by Geography - Analysis and Forecast to 2019" report to their offering.
The global glaucoma surgery devices market was valued at $210.3 million in 2014, and is projected to reach $314.3 million by 2019, at a CAGR of 8.4% during the period under consideration. Among the types considered in the market analysis, the glaucoma drainage devices segment dominated the overall market in 2014, and is estimated to reach a market size of $175.4 million by 2019.
The North American region accounted for the largest share of the total global glaucoma surgery devices market in 2014, and is forecast to reach a market value of $138.3 million by 2019, at a CAGR of 7.8% during the given forecast period. Globally, the Asian market is expected to be the fastest-growing market in the global glaucoma surgery devices market. The Asian market was valued at $45.3 million in 2014 and is expected to reach $74.2 million by 2019, at the fastest CAGR of 10.4% from 2014 to 2019. The market in Asia is driven by both established and emerging markets. The success in more developed regions countries such as Japan continues to support opportunities for growth in the Asian region. Similar opportunities exist in several developing regions, specifically India, China, and South Korea.
The increasing prevalence of eye-related disorders, such as macular degeneration and diabetic retinopathy; the aging population worldwide; and the rising government initiatives towards healthcare infrastructure in developing countries are among the key driving factors for the growth of the global glaucoma surgery device market.
The aging population factor is a significant driver for the growth of the global market, boosting sales for products directed at addressing diseases related to eyes, and emphasizing early intervention through diagnosis and treatments. The global population will continue to grow and age; older people are expected to account for 20% to 25% of each region's total population by 2020. This suggests a steady market path for the glaucoma surgery devices in the coming years.
Based on end-users, the global market has been categorized into private eye clinics, hospitals, and other end-users, in which the private eye clinics segment led the glaucoma surgery device market in 2014, and is projected to reach a market size of $173.7 million by 2019.
The key players in the global glaucoma surgery device market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and Iridex Corporation (U.S.).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Market Overview
5 Glaucoma Surgery Devices By Type
6 Glaucoma Surgery Devices By End-User
7 Glaucoma Surgery Devices By Geography
8 Glaucoma Surgery Devices : Competitive Landscape
9 Glaucoma Surgery Devices By Company
For more information visit http://www.researchandmarkets.com/research/hkf3n4/global_glaucoma
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article